B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sb 203580

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sb 203580, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sb
35 shared targets
vandetanib
35 shared targets
doramapimod
30 shared targets
canertinib
34 shared targets
saracatinib
20 shared targets
gefitinib
25 shared targets
raf
22 shared targets
erlotinib
29 shared targets
Afatinib
22 shared targets · score 50.1
cep
17 shared targets
Loading evidence profile...

This evidence profile for Sb 203580 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.